Cargando…
The road to elimination of hepatitis C: analysis of cures versus new infections in 91 countries
BACKGROUND: Hepatitis C (HCV) can only be eradicated if annual rates of cure (SVR) are consistently and significantly higher than new HCV infections, across many countries. In 2016, the WHO called for a 90% reduction in new HCV infection by 2030. Direct-acting antivirals (DAA) can cure the majority...
Autores principales: | Hill, Andrew M, Nath, Sanjay, Simmons, Bryony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mediscript Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518239/ https://www.ncbi.nlm.nih.gov/pubmed/28758018 |
Ejemplares similares
-
Initial success from a public health approach to hepatitis C testing, treatment and cure in seven countries: the road to elimination
por: Boeke, Caroline E, et al.
Publicado: (2020) -
Successes and Challenges on the Road to Cure Hepatitis C
por: Horner, Stacy M., et al.
Publicado: (2015) -
Minimum Costs for Producing Hepatitis C Direct-Acting Antivirals for Use in Large-Scale Treatment Access Programs in Developing Countries
por: Hill, Andrew, et al.
Publicado: (2014) -
Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
por: Hill, Andrew, et al.
Publicado: (2016) -
Prices of second-line antiretroviral treatment for middle-income countries inside versus outside sub-Saharan Africa
por: Simmons, Bryony, et al.
Publicado: (2014)